Numb. | TREATMENT //carcinogen (if not AOM) and /mice (if not rats) | Category | Author, year (click name for abstract) | Potency on tumor incidence | Tumor percent inhibition | Cancer percent inhibition | Potency on tumor multiplic. | Protocol | blinded scoring | Ro- dents | carcinogen N x dose | weeks | Tum. in Contrl | No. of Contrl Rats | Tum. in treatd | No. of Treated Rats | Potency on tumor incidence | Carcin. in ctrl | Contrl rats | Carcin. in treatd | Treated rats | Cancer percent inhibition | Multiplic. in contrl | Multiplic. in treatd | Potency on tumor multiplic. | Agent (3 lett.) or comment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T218 | Bifidobact. longum 2% | fibact | Singh 97 | 1.44 | 30 | 2.2 | both | Rf' | aom 2x15 | 40 | 23 | 30 | 16 | 30 | 1.44 | 1.80 | 0.83 | 2.2 | bif |
To download data in Excel: select data (Ctrl-A), copy/paste (Ctrl-C) in an empty Excel page (Ctrl-V)